ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration 04 May 2023 An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial. Find out more Show/Hide